CIK: 0001802528 · Show all filings
Period: Q2 2020 (← Previous) (Next →)
Filing Date: Aug 4, 2020
Total Value ($000): $224,208 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ACAD | ACADIA PHARMACEUTICALS INC | 585,517 | $28,380 | 12.7% | $43.17 | +11.2% | COM | 004225108 |
| INSM | INSMED INC | 1,010,797 | $27,837 | 12.4% | $20.45 | +16.0% | COM PAR $.01 | 457669307 |
| — | ZOGENIX INC | 971,875 | $26,250 | 11.7% | $37.89 | — | COM NEW | 98978L204 |
| FOLD | AMICUS THERAPEUTICS INC | 1,505,395 | $22,701 | 10.1% | $9.80 | +24.3% | COM | 03152W109 |
| AXSM | AXSOME THERAPEUTICS INC | 216,098 | $17,781 | 7.9% | $80.93 | -4.9% | COM | 05464T104 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 603,890 | $16,577 | 7.4% | $24.87 | +32.2% | COM | 462260100 |
| — | ALLAKOS INC | 178,662 | $12,839 | 5.7% | $81.12 | — | COM | 01671P100 |
| — | NEOLEUKIN THERAPEUTICS INC | 770,073 | $12,783 | 5.7% | $12.32 | — | COM | 64049K104 |
| — | KARYOPHARM THERAPEUTICS INC | 652,351 | $12,356 | 5.5% | $19.15 | — | COM | 48576U106 |
| — | TRILLIUM THERAPEUTICS INC | 1,483,181 | $11,999 | 5.4% | $4.04 | — | COM NEW | 89620X506 |
| ARGX | ARGENX SE | 50,450 | $11,363 | 5.1% | $160.52 | — | SPONSORED ADR | 04016X101 |
| — | AMARIN CORP PLC | 1,403,237 | $9,710 | 4.3% | $15.57 | — | SPONS ADR NEW | 023111206 |
| ENTA | ENANTA PHARMACEUTICALS INC | 169,949 | $8,533 | 3.8% | $61.59 | -16.0% | COM | 29251M106 |
| — | KINIKSA PHARMACEUTICALS LTD | 200,125 | $5,099 | 2.3% | $11.83 | — | COM CL A | G5269C101 |